FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2895887580> ?p ?o ?g. }

• W2895887580 endingPage "693" @default.
• W2895887580 startingPage "688" @default.
• W2895887580 abstract "Background Hidradenitis suppurativa (HS) is a chronic, inflammatory disease affecting the apocrine glands of the axillary, groin, and mammary regions with significant physical and psychosocial sequelae. Surgical excision of the affected tissue is the criterion standard treatment. Advanced cases of axillary HS are associated with high rates of recurrence and require extensive surgical resection with challenging reconstruction associated with risk of postoperative complications. The most effective method for reconstruction of the axilla after excision of HS is yet to be identified. Objectives The aim of the study was to evaluate the results of the use of pedicled thoracodorsal artery perforator (TDAP) flap as a method of reconstruction for axillary efect result from wide surgical excision as a line of treatment for stage II and III HS of the axilla. Patient and Methods The study included 20 patients with stage II and III (Hurley staging system) HS of the axilla, 18 male and 2 women treated by wide local excision and reconstruction by rotational TDAP flap. At the end of follow-up, outcome is judged by complete remission of disease, comparing preoperative shoulder function (using Constant-Murley shoulder outcome score), and quality of life (using dermatology life quality index) with postoperative results after 1 year, plus durability of reconstruction, donor site morbidity, overall aesthetic outcome, and patient's satisfaction. Results The mean ± SD follow-up period was 30 ± 5.2 months (range = 12–60 months). Four patients (20%) were treated for their right side, 8 patients (40%) for their left side, and 8 patients (40%) were treated bilaterally, so we perform 28 operations for 20 patients. The treated patients with stage II disease were 16 (57.14%) and with stage III disease were 12 (42.85%). The size of the defects was usually approximately 10 × 15 cm. By the end of follow-up period, all patient showed complete remission of the disease with improvement in both shoulder function and quality of life, whereas 1 flap (3.57%) was complicated by bleeding treated by reoperation, 2 flaps (7.14%) complicated by wound infection that was treated conservatively, 3 other flaps (10.71%) showed wide scare at insight of the flaps, and 1 flap (3.57%) developed hypertrophic scare at donor site of the flap. Conclusions Surgical treatment of stage II and III HS of axilla and reconstruction by rotational TDAP flap provides good aesthetic and functional results with 100% success rate in eradicating and complete remission of the disease during follow-up period and accepted complication rate." @default.
• W2895887580 created "2018-10-26" @default.
• W2895887580 creator A5007125547 @default.
• W2895887580 creator A5034607924 @default.
• W2895887580 creator A5056062473 @default.
• W2895887580 creator A5065098515 @default.
• W2895887580 creator A5071748732 @default.
• W2895887580 creator A5091097790 @default.
• W2895887580 date "2018-12-01" @default.
• W2895887580 modified "2023-10-06" @default.
• W2895887580 title "Outcome of Pedicled Thoracodorsal Artery Perforator Flap in the Surgical Treatment of Stage II and III Hidradenitis Suppurativa of Axilla" @default.
• W2895887580 cites W1974455447 @default.
• W2895887580 cites W1983475506 @default.
• W2895887580 cites W2008456796 @default.
• W2895887580 cites W2019904832 @default.
• W2895887580 cites W2024705390 @default.
• W2895887580 cites W2051548645 @default.
• W2895887580 cites W2067214690 @default.
• W2895887580 cites W2072514920 @default.
• W2895887580 cites W2082205727 @default.
• W2895887580 cites W2094180264 @default.
• W2895887580 cites W2094941448 @default.
• W2895887580 cites W2104384760 @default.
• W2895887580 cites W2115066354 @default.
• W2895887580 cites W2150743420 @default.
• W2895887580 cites W4254817125 @default.
• W2895887580 cites W85084227 @default.
• W2895887580 doi "https://doi.org/10.1097/sap.0000000000001658" @default.
• W2895887580 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30325840" @default.
• W2895887580 hasPublicationYear "2018" @default.
• W2895887580 type Work @default.
• W2895887580 sameAs 2895887580 @default.
• W2895887580 citedByCount "21" @default.
• W2895887580 countsByYear W28958875802019 @default.
• W2895887580 countsByYear W28958875802020 @default.
• W2895887580 countsByYear W28958875802021 @default.
• W2895887580 countsByYear W28958875802022 @default.
• W2895887580 countsByYear W28958875802023 @default.
• W2895887580 crossrefType "journal-article" @default.
• W2895887580 hasAuthorship W2895887580A5007125547 @default.
• W2895887580 hasAuthorship W2895887580A5034607924 @default.
• W2895887580 hasAuthorship W2895887580A5056062473 @default.
• W2895887580 hasAuthorship W2895887580A5065098515 @default.
• W2895887580 hasAuthorship W2895887580A5071748732 @default.
• W2895887580 hasAuthorship W2895887580A5091097790 @default.
• W2895887580 hasConcept C121608353 @default.
• W2895887580 hasConcept C126322002 @default.
• W2895887580 hasConcept C141071460 @default.
• W2895887580 hasConcept C146357865 @default.
• W2895887580 hasConcept C151730666 @default.
• W2895887580 hasConcept C159110408 @default.
• W2895887580 hasConcept C2775944032 @default.
• W2895887580 hasConcept C2776002364 @default.
• W2895887580 hasConcept C2776608951 @default.
• W2895887580 hasConcept C2777757722 @default.
• W2895887580 hasConcept C2778303017 @default.
• W2895887580 hasConcept C2779134260 @default.
• W2895887580 hasConcept C2779687288 @default.
• W2895887580 hasConcept C2779912925 @default.
• W2895887580 hasConcept C2779951463 @default.
• W2895887580 hasConcept C2779967601 @default.
• W2895887580 hasConcept C2781001896 @default.
• W2895887580 hasConcept C530470458 @default.
• W2895887580 hasConcept C71924100 @default.
• W2895887580 hasConcept C86803240 @default.
• W2895887580 hasConceptScore W2895887580C121608353 @default.
• W2895887580 hasConceptScore W2895887580C126322002 @default.
• W2895887580 hasConceptScore W2895887580C141071460 @default.
• W2895887580 hasConceptScore W2895887580C146357865 @default.
• W2895887580 hasConceptScore W2895887580C151730666 @default.
• W2895887580 hasConceptScore W2895887580C159110408 @default.
• W2895887580 hasConceptScore W2895887580C2775944032 @default.
• W2895887580 hasConceptScore W2895887580C2776002364 @default.
• W2895887580 hasConceptScore W2895887580C2776608951 @default.
• W2895887580 hasConceptScore W2895887580C2777757722 @default.
• W2895887580 hasConceptScore W2895887580C2778303017 @default.
• W2895887580 hasConceptScore W2895887580C2779134260 @default.
• W2895887580 hasConceptScore W2895887580C2779687288 @default.
• W2895887580 hasConceptScore W2895887580C2779912925 @default.
• W2895887580 hasConceptScore W2895887580C2779951463 @default.
• W2895887580 hasConceptScore W2895887580C2779967601 @default.
• W2895887580 hasConceptScore W2895887580C2781001896 @default.
• W2895887580 hasConceptScore W2895887580C530470458 @default.
• W2895887580 hasConceptScore W2895887580C71924100 @default.
• W2895887580 hasConceptScore W2895887580C86803240 @default.
• W2895887580 hasIssue "6" @default.
• W2895887580 hasLocation W28958875801 @default.
• W2895887580 hasLocation W28958875802 @default.
• W2895887580 hasOpenAccess W2895887580 @default.
• W2895887580 hasPrimaryLocation W28958875801 @default.
• W2895887580 hasRelatedWork W1557800102 @default.
• W2895887580 hasRelatedWork W1976033671 @default.
• W2895887580 hasRelatedWork W2034326188 @default.
• W2895887580 hasRelatedWork W2112561111 @default.
• W2895887580 hasRelatedWork W2342389530 @default.
• W2895887580 hasRelatedWork W2410365971 @default.
• W2895887580 hasRelatedWork W2412839073 @default.
• W2895887580 hasRelatedWork W2809357840 @default.

• next